These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3130831)

  • 1. Valproic acid loading during intensive monitoring.
    Lanska DJ; Osorio I
    Arch Neurol; 1988 Jun; 45(6):602-3. PubMed ID: 3130831
    [No Abstract]   [Full Text] [Related]  

  • 2. [State of confusion induced by valproic acid and reversed after administration of clonazepam].
    Larrieu JL; Lagueny A; Julien J
    Rev Electroencephalogr Neurophysiol Clin; 1985 Sep; 15(2):179-84. PubMed ID: 3934722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dipropylacetate (sodium valproate) and carbamazepine : a suspicious anticonvulsant combination].
    Lhermitte F; Marteau R; Serdaru M
    Nouv Presse Med; 1978 Nov; 7(41):3780. PubMed ID: 366563
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute valproic acid toxicity at therapeutic concentrations.
    Wason S; Savitt D
    Clin Pediatr (Phila); 1985 Aug; 24(8):466-7. PubMed ID: 3924463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe vigilance disturbances: a rare complication of sodium valproate treatment (author's transl)].
    Cenraud B; Pautrizel B; Berets O; Loiseau P
    Rev Electroencephalogr Neurophysiol Clin; 1980; 10(4):376-80. PubMed ID: 6795695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Valproic acid and stupor].
    Selten JP
    Ned Tijdschr Geneeskd; 1990 Dec; 134(50):2451-2. PubMed ID: 2263279
    [No Abstract]   [Full Text] [Related]  

  • 7. Confusion, a rather serious adverse drug reaction with valproic acid: a review of the French Pharmacovigilance database.
    Bondon-Guitton E; Sommet A; Montastruc JL;
    Pharmacopsychiatry; 2009 Mar; 42(2):61-5. PubMed ID: 19308880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproic acid and stupor].
    Vanhooren GT
    Ned Tijdschr Geneeskd; 1991 Feb; 135(5):191-2. PubMed ID: 2002873
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of autonomy related to valproic acid intake.
    Gaubert ML; Cougnaud A; Ghali A; Bruhat C; Diquet B; Berrut G
    J Am Geriatr Soc; 2006 Dec; 54(12):1971. PubMed ID: 17198529
    [No Abstract]   [Full Text] [Related]  

  • 10. Clumsiness, confusion, coma, and valproate.
    Ellaway CJ; Bennetts B; Tuck RR; Wilcken B
    Lancet; 1999 Apr; 353(9162):1408. PubMed ID: 10227223
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stupor encephalopathy caused by sodium valproate].
    Visticot F; Montreuil G
    Rev Med Interne; 1994 May; 15(5):365-6. PubMed ID: 8059168
    [No Abstract]   [Full Text] [Related]  

  • 12. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.
    Nicolai J; Aldenkamp AP; Huizenga JR; Teune LK; Brouwer OF
    J Clin Psychopharmacol; 2007 Apr; 27(2):221-4. PubMed ID: 17414255
    [No Abstract]   [Full Text] [Related]  

  • 13. Drowsiness and disorientation in a woman with depression.
    Uthamalingam S; Kumar S; Vasudevan AR; Winters WG
    J Am Geriatr Soc; 2005 Sep; 53(9):1638-9. PubMed ID: 16137309
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stupor associated with the treatment of epilepsy with valproate].
    Skjødt T; Sørensen T
    Ugeskr Laeger; 1984 Apr; 146(15):1137-8. PubMed ID: 6429914
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible cognitive and neurological symptoms during valproic acid therapy.
    Hommet C; Mondon K; de Toffol B; Constans T
    J Am Geriatr Soc; 2007 Apr; 55(4):628. PubMed ID: 17397449
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reversible Parkinsonism and cognitive impairment following treatment with valproate].
    Toribio-Díaz ME; Morera-Guitart J; Palao-Duarte S
    Rev Neurol; 2008 Oct 1-15; 47(7):390-1. PubMed ID: 18841554
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there a difference between various presentations of valproate for cognitive outcome after in utero exposure?
    Gelisse P; Genton P; Crespel A
    Epilepsia; 2016 Mar; 57(3):523-4. PubMed ID: 26948846
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproate-induced pseudoatrophy: expanding the clinical and imaging spectrum.
    Lovett M; Skidmore DL; Mohamed IS
    Pediatr Neurol; 2014 Aug; 51(2):284-5. PubMed ID: 25079580
    [No Abstract]   [Full Text] [Related]  

  • 19. [Confusion and delusion syndrome due to oxolinic acid (1)].
    Danion JM; Imbs JL; Zeis P; Singer L
    Ann Med Psychol (Paris); 1982 Mar; 140(3):351-2. PubMed ID: 7137759
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute akinetic crisis with marked cognitive impairment due to Valproate treatment.
    Reif A; Hamelbeck B; Pfuhlmann B
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):356-7. PubMed ID: 12673616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.